
Insurance · NYSE: AFL
Aflac earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends December · next results expected around 3 Feb 2027
Latest: Q3 2026
Aflac Japan ceded about ¥500 billion of cancer-insurance reserves to its Bermuda reinsurer, freeing capital while Japan sales dipped against a strong Miraito launch comparison and a cyber disruption.
Aflac Japan's sales fell against last year's strong Miraito cancer insurance launch. Tsumitasu savings-type insurance and the new Anshin Palette medical product both grew. A network incident forced the company to pause direct mail and outbound calls, and sales were back to normal by October. In the U.S., group life, absence and disability, and network dental and vision drove growth, with dental increasingly sold alongside voluntary benefits.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $5.4B * |
| Q1 2025 | $3.4B |
| Q2 2025 | $4.2B |
| Q3 2025 | $4.7B |
| Q4 2025 | $4.9B * |
| Q1 2026 | $4.3B |
| Q2 2026 | $4.1B |
| Q3 2026 | $3.3B |
Data
| Q1 2025 | $0.05 |
| Q2 2025 | $1.11 |
| Q3 2025 | $3.08 |
| Q1 2026 | $1.98 |
| Q2 2026 | $1.63 |
| Q3 2026 | $0.61 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4Bd | $3.4B | $4.2B | $4.7B | $4.9Bd | $4.3B | $4.1B | $3.3B |
| Net income | $1.9Bd | $29.0M | $599.0M | $1.6B | $1.4Bd | $1.0B | $825.0M | $303.0M |
| Diluted EPS | — | $0.05 | $1.11 | $3.08 | — | $1.98 | $1.63 | $0.61 |
| Operating cash flow | $333.0Md | $589.0M | $399.0Md | $1.3Bd | $315.0Md | $968.0M | $112.0Md | $1.2Bd |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-K and 10-Q filings
- 5 Nov 202610-Q for the period ended 30 Sep 2026SEC ↗
- 7 Aug 202610-Q for the period ended 30 Jun 2026SEC ↗
- 6 May 202610-Q for the period ended 31 Mar 2026SEC ↗
- 25 Feb 202610-K for the period ended 31 Dec 2025SEC ↗
- 5 Nov 202510-Q for the period ended 30 Sep 2025SEC ↗
- 5 Aug 202510-Q for the period ended 30 Jun 2025SEC ↗
- 7 May 202510-Q for the period ended 31 Mar 2025SEC ↗
- 26 Feb 202510-K for the period ended 31 Dec 2024SEC ↗